Is IG-SRT as effective as Mohs surgery?

Yes. Head-to-head comparisons and clinical outcomes indicate that IG-SRT is just as effective as Mohs surgery for treating basal and squamous cell skin cancers. Mohs surgery is known for high cure rates (around 96–98% for primary tumors), and IG-SRT’s cure rates have been measured at 99% or above. In one analysis, IG-SRT achieved a 99.5% cure rate for non-melanoma skin cancers, versus approximately 98% with Mohs. That difference is minimal and even favors IG-SRT slightly. Practically speaking, both treatments are extremely effective when performed appropriately. This equivalence has been recognized in the dermatology community – IG-SRT can cure skin cancer as reliably as surgery in eligible cases. So patients who choose IG-SRT forgo surgery but do not forgo efficacy.